Analyses of neurobehavioral screening data: benchmark dose estimation.

[1]  Yiliang Zhu,et al.  Dose–time–response modeling of longitudinal measurements for neurotoxicity risk assessment , 2005 .

[2]  Yiliang Zhu,et al.  Analyses of neurobehavioral screening data: dose-time-response modeling of continuous outcomes. , 2005, Regulatory toxicology and pharmacology : RTP.

[3]  Yiliang Zhu.  DOSE-RESPONSE MODELING IN HEALTH RISK ASSESSMENT , 2003 .

[4]  D Krewski,et al.  Procedures for calculating benchmark doses for health risk assessment. , 1998, Regulatory toxicology and pharmacology : RTP.

[5]  W Leisenring,et al.  Statistical properties of the NOAEL. , 1992, Regulatory toxicology and pharmacology : RTP.

[6]  Scott L. Zeger,et al.  Bootstrapping generalized linear models , 1991 .

[7]  D. Barnes,et al.  Reference dose (RfD): description and use in health risk assessments. , 1988, Regulatory toxicology and pharmacology : RTP.

[8]  D W Gaylor,et al.  Issues in qualitative and quantitative risk analysis for developmental toxicology. , 1988, Risk analysis : an official publication of the Society for Risk Analysis.

[9]  K S Crump,et al.  A new method for determining allowable daily intakes. , 1984, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[10]  B. K. Nelson,et al.  The IPCS Collaborative Study on Neurobehavioral Screening Methods: V. Results of chemical testing. Steering Group. , 1997, Neurotoxicology.

[11]  H. Tilson,et al.  The IPCS Collaborative Study on Neurobehavioral Screening Methods: II. Protocol design and testing procedures. , 1997, Neurotoxicology.